Proscar Tablet, Film Coated
Product Images NDC 78206-153

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Proscar (NDC 78206-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Finasteride Chemical Structure (Proscar 01)

Chemical structure of finasteride, the active ingredient in PROSCAR 5 mg oral film-coated tablets by Organon LLC. The diagram shows the molecular framework including rings and functional groups characteristic of finasteride.*

FDA Label Image

Image Of Figure 1 (Proscar 02)

A line graph showing mean change from baseline over three years plus a baseline point, comparing Finasteride and Placebo groups. The vertical axis represents the mean change from baseline with values ranging from 0 to -6, and the horizontal axis shows time points from Baseline through Year 3. The graph includes sample sizes for each time point for both groups.*

FDA Label Image

Image Of Figure 2 (Proscar 03)

A line graph comparing cumulative percent of patients experiencing events over 48 months for Finasteride and placebo groups. The x-axis represents observation time in months, and the y-axis shows percent of patients. Data tables below detail event counts and numbers at risk annually for each group.*

FDA Label Image

Image Of Figure 3 (Proscar 04)

A line graph comparing the cumulative percent of patients over observation time (up to 48 months) between Finasteride and placebo groups. The y-axis represents percent of patients, and the x-axis shows observation time in months. Two lines plot the progression for Finasteride (solid line) and placebo (dotted line), with data on number of events, cumulative events, and patients at risk per year for both groups shown below.*

FDA Label Image

Image Of Figure 4 (Proscar 05)

A line graph showing mean percent change from baseline over five time points (Baseline, Year 1 to Year 4) for two groups: Placebo and Finasteride. The Y-axis represents mean percent change, with Placebo group values decreasing and Finasteride group values increasing over time.*

FDA Label Image

Image Of Figure 5 (Proscar 06)

A line graph showing the percent with event over time in years from randomization, comparing four groups: Placebo, Finasteride, Doxazosin, and Combination. The vertical axis represents percent with event, and the horizontal axis represents years from randomization up to 5.5 years. Each group is represented with distinct symbols marking progression over time.*

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Packaging label for PROSCAR (finasteride) Tablets 5 mg, a film-coated tablet for oral use. The label shows the product name, strength, usage warnings, storage instructions, and contains a barcode. It indicates the product is Rx only, includes 30 tablets per package, and is labeled by Organon LLC. A small blue tablet imprinted with "MSD 72" is depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.